USC.edu
Are you a Patient?

Lynda Diane Roman, MD

Associate Professor of Obstetrics & Gynecology

Division Chief, Gynecologic Oncology

Image of Lynda Diane Roman, MD
Websites
Is this your profile? Click to edit
Phone +1 323 409 3405
Email lroman@usc.edu
CTSI Profile

Overview

Dr. Roman completed her fellowship in gynecologic oncology at the MD Anderson Cancer Center in Houston, Texas in 1991. She is the Director of the Division of Gynecologic Oncology at the University of Southern California and co-director of the Lynne Cohen Preventive Cancer Care Clinic at the USC/Norris Cancer Center. She is actively involved in clinical trials and collaborative translational efforts.

Publications

  • Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapyAm J Obstet Gynecol. 2020 07; 223(1):103. e1-103. e13. . View in PubMed
  • Cervical conization of adenocarcinoma in situ: a predicting model of residual diseaseAm J Obstet Gynecol. 2014 Apr; 210(4):366. e1-366. e5. . View in PubMed
  • Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy aloneAm J Obstet Gynecol. 2020 05; 222(5):484. e1-484. e15. . View in PubMed
  • Substantial variability in ovarian conservation at hysterectomy for endometrial hyperplasiaAm J Obstet Gynecol. 2022 08; 227(2):255. e1-255. e18. . View in PubMed
  • Survival outcome prediction in cervical cancer: Cox models vs deep-learning modelAm J Obstet Gynecol. 2019 04; 220(4):381. e1-381. e14. . View in PubMed
  • Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancerAm J Obstet Gynecol. 2017 11; 217(5):580. e1-580. e10. . View in PubMed
  • Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer: trachelectomy vs hysterectomyAm J Obstet Gynecol. 2018 11; 219(5):461. e1-461. e18. . View in PubMed
  • Trachelectomy for reproductive-aged women with early-stage cervical cancer: minimally invasive surgery versus laparotomyAm J Obstet Gynecol. 2019 05; 220(5):469. e1-469. e13. . View in PubMed
  • Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United StatesAm J Obstet Gynecol. 2021 10; 225(4):399. e1-399. e32. . View in PubMed
  • The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United StatesAm J Obstet Gynecol. 2020 11; 223(5):721. e1-721. e18. . View in PubMed
  • Cesarean hysterectomy for placenta accreta spectrum: Surgeon specialty-specific assessment Gynecol Oncol. 2024 Apr 10; 186:85-93. . View in PubMed
  • Increasing utilization of intrauterine device insertion at hysteroscopic endometrial evaluation for patients with endometrial hyperplasia Arch Gynecol Obstet. 2024 Mar 22. . View in PubMed
  • Diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma Obstet Gynecol. 2024 Mar 21. . View in PubMed
  • Racial and ethnic differences in early-death among gynecologic malignancy Am J Obstet Gynecol. 2024 Mar 07. . View in PubMed
  • Lymph Node Isolated Tumor Cells in Patients With Endometrial Cancer JAMA Netw Open. 2024 Mar 04; 7(3):e240988. . View in PubMed
  • Low-grade endometrioid endometrial cancer with adnexal only metastasis: Evaluation of de-escalation of adjuvant therapy Eur J Cancer. 2024 Mar; 200:113533. . View in PubMed
  • An absence of translated consent forms limits oncologic clinical trial enrollment for limited English proficiency participants Gynecol Oncol. 2024 Jan; 180:86-90. . View in PubMed
  • OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer Clin Cancer Res. 2023 Dec 15; 29(24):5196-5206. . View in PubMed
  • Reconstructive Surgery at Hysterectomy for Patients With Uterine Prolapse and Gynecologic Malignancy Obstet Gynecol. 2023 Dec 01; 142(6):1487-1490. . View in PubMed
  • Concurrent Minimally Invasive Gynecologic Procedures at the Time of Laparoscopic Cholecystectomy Obstet Gynecol. 2023 Dec 01; 142(6):1491-1495. . View in PubMed
  • Benefits of the Enhanced Recovery After Surgery (ERAS) Pathway With Quadratus Lumborum Blocks for Minimally Invasive Gynecologic Surgery Patients: A Retrospective Cohort Study Cureus. 2023 Nov; 15(11):e49183. . View in PubMed
  • Validation of the 2023 FIGO staging schema for advanced endometrial cancer Eur J Cancer. 2023 Nov; 193:113316. . View in PubMed
  • Temporal trends of failure-to-rescue following perioperative complications in vulvar cancer surgery in the United States Gynecol Oncol. 2023 Oct; 177:1-8. . View in PubMed
  • Contraception and sterilization selection at delivery among pregnant patients with malignancy Acta Obstet Gynecol Scand. 2023 Aug 14. . View in PubMed
  • Correction: Lymph node evaluation for endometrial hyperplasia: a nationwide analysis of minimally invasive hysterectomy in the ambulatory setting Surg Endosc. 2023 Aug; 37(8):6602. . View in PubMed
  • Correction: Lymph node evaluation for endometrial hyperplasia: a nationwide analysis of minimally invasive hysterectomy in the ambulatory setting Surg Endosc. 2023 Aug; 37(8):6603. . View in PubMed
  • Utilizations and characteristics of ovarian conservation at hysterectomy for cervical carcinoma in situ Int J Gynaecol Obstet. 2023 May; 161(2):631-639. . View in PubMed
  • Variation of in vitro digestibility of pea protein powder dispersions from commercially available sources Food Chem. 2023 Feb 01; 401:134178. . View in PubMed
  • Trends in the use of indocyanine green for sentinel lymph node mapping in vulvar cancer Am J Obstet Gynecol. 2023 10; 229(4):466-468. . View in PubMed
  • Lymph node evaluation for endometrial hyperplasia: a nationwide analysis of minimally invasive hysterectomy in the ambulatory setting Surg Endosc. 2023 08; 37(8):6163-6171. . View in PubMed
  • Increasing trends of cervical conization with lymph node evaluation for fertility-sparing surgery in early cervical cancer Gynecol Oncol. 2023 06; 173:122-129. . View in PubMed
  • Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer Gynecol Oncol. 2023 06; 173:49-57. . View in PubMed
  • Cancer Stage-Shifting with Sentinel Lymph Node Biopsy in Low-Grade Endometrial Cancer Ann Surg Oncol. 2023 06; 30(6):3191-3193. . View in PubMed
  • Intraoperative rupture and chemotherapy use in stage I ovarian cancer Eur J Obstet Gynecol Reprod Biol. 2023 05; 284:200-202. . View in PubMed
  • Temporal trends of hysterectomy modality for premalignant gynecologic pathology in the United States, 2016-2019 J Surg Oncol. 2023 05; 127(6):1079-1081. . View in PubMed
  • The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research Expert Rev Anticancer Ther. 2023 04; 23(4):385-395. . View in PubMed
  • Utilization of sentinel lymph node biopsy in the early ovarian cancer surgery Arch Gynecol Obstet. 2023 02; 307(2):525-532. . View in PubMed
  • Secondary ovarian cancer after external beam radiotherapy for nonovarian pelvic malignancy Eur J Surg Oncol. 2023 02; 49(2):461-467. . View in PubMed
  • Metastatic extent-specific prognosis of women with stage IVB cervical cancer: multiple versus single distant organ involvement Arch Gynecol Obstet. 2023 02; 307(2):533-540. . View in PubMed
  • Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy for Ovarian Cancer Prevention: A Cost-effectiveness Analysis Ann Surg. 2023 05 01; 277(5):e1116-e1123. . View in PubMed
  • Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas JAMA Netw Open. 2023 06 01; 6(6):e2318602. . View in PubMed
  • Placenta previa percreta with surrounding organ involvement: a proposal for management Int J Gynecol Cancer. 2023 10 02; 33(10):1633-1644. . View in PubMed
  • Assessment of Gender-Specific COVID-19 Case Fatality Risk per Malignant Neoplasm Type JAMA Oncol. 2023 08 01; 9(8):1113-1118. . View in PubMed
  • Utilization of lymph node evaluation at hysterectomy for cervical carcinoma in situ J Surg Oncol. 2022 Dec; 126(8):1543-1550. . View in PubMed
  • Our Space of Morrow Int J Gynecol Cancer. 2022 Nov 21. . View in PubMed
  • Side-to-end reanastomosis after low-anterior resection (STELAR): Outcomes, feasibility, and description of procedure performed by a gynecologic oncology service J Surg Oncol. 2022 Sep; 126(3):563-570. . View in PubMed
  • Cellular lipids and protein alteration during biodegradation of expanded polystyrene by mealworm larvae under different feeding conditions Chemosphere. 2022 Aug; 300:134420. . View in PubMed
  • Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer Eur J Obstet Gynecol Reprod Biol. 2022 Aug; 275:91-96. . View in PubMed
  • Trends and characteristics of ovarian conservation at hysterectomy for young women with cervical cancer Eur J Obstet Gynecol Reprod Biol. 2022 Jun; 273:59-64. . View in PubMed
  • Incorporation of vaginal brachytherapy to external beam radiotherapy in adjuvant therapy for high-risk early-stage cervical cancer: A comparative study Brachytherapy. 2022 Mar-Apr; 21(2):141-150. . View in PubMed
  • Malignant peritoneal cytology in endometrial cancer: a contemporary review Expert Rev Anticancer Ther. 2022 09; 22(9):947-955. . View in PubMed
  • Population incidence and characteristics of secondary breast cancer after uterine cancer: a competing risk analysis Arch Gynecol Obstet. 2022 09; 306(3):865-874. . View in PubMed
  • Association between hysterectomy wait-time and all-cause mortality for micro-invasive cervical cancer: treatment implications during the coronavirus pandemic Arch Gynecol Obstet. 2022 07; 306(1):283-287. . View in PubMed
  • Incorporation of sentinel lymph node biopsy in cervical cancer surgery: Recent US. trends. Eur J Surg Oncol. 2022 06; 48(6):1407-1413. . View in PubMed
  • Population-level uptake of neoadjuvant chemotherapy for stage IVB endometrial cancer Gynecol Oncol. 2022 06; 165(3):428-436. . View in PubMed
  • Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer Gynecol Oncol. 2022 05; 165(2):264-269. . View in PubMed
  • Uptake in sentinel lymph node biopsy for endometrial cancer with T3 classification Gynecol Oncol. 2022 05; 165(2):361-368. . View in PubMed
  • Hormonal therapy or chemotherapy for early-stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study Gynecol Oncol. 2022 05; 165(2):353-360. . View in PubMed
  • Population-level trends and outcomes of sentinel lymph node biopsy in vulvar cancer surgery in the United States Gynecol Oncol. 2022 03; 164(3):651-657. . View in PubMed
  • Sentinel lymph node biopsy for vulvar melanoma: trends in tumor stage-specific utilization Am J Obstet Gynecol. 2022 03; 226(3):438-440. . View in PubMed
  • Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpoints Arch Gynecol Obstet. 2022 02; 305(2):439-447. . View in PubMed
  • Proposal of a simple 2-hand technique at cesarean hysterectomy for placenta accreta spectrum Arch Gynecol Obstet. 2022 01; 305(1):1-5. . View in PubMed
  • Sentinel lymph node biopsy for stage II endometrial cancer: Recent utilization and outcome in the United States Gynecol Oncol. 2022 01; 164(1):46-52. . View in PubMed
  • Utilization and Outcomes of Sentinel Lymph Node Biopsy for Early Endometrial Cancer Obstet Gynecol. 2022 05 01; 139(5):809-820. . View in PubMed
  • Validation of the 2021 FIGO staging schema for advanced vulvar cancer Int J Gynecol Cancer. 2022 04 04; 32(4):474-479. . View in PubMed
  • Gynecologic oncologists in surgery for placenta accreta spectrum: a survey for practice, experience, and interest Int J Gynecol Cancer. 2022 11 07; 32(11):1433-1442. . View in PubMed
  • Increasing Utilization of Surgical Nodal Evaluation at Hysterectomy for Endometrial Hyperplasia Obstet Gynecol. 2022 06 01; 139(6):1152-1154. . View in PubMed
  • Assessment of Severe Maternal Morbidity and Mortality in Pregnancies Complicated by Cancer in the US JAMA Oncol. 2022 08 01; 8(8):1213-1216. . View in PubMed
  • Epigenetic Dysregulation of Trophoblastic Gene Expression in Gestational Trophoblastic Disease Biomedicines. 2021 Dec 17; 9(12). . View in PubMed
  • Intraoperative tumor spill during minimally invasive hysterectomy for endometrial cancer: A survey study on experience and practice Eur J Obstet Gynecol Reprod Biol. 2021 Dec; 267:256-261. . View in PubMed
  • Association Between Adjuvant Therapy and Survival in Stage II-III Endometrial Cancer: Influence of Malignant Peritoneal Cytology Ann Surg Oncol. 2021 Nov; 28(12):7591-7603. . View in PubMed
  • Minimally Invasive Surgery and Surgical Volume-Specific Survival and Perioperative Outcome: Unmet Need for Evidence in Gynecologic Malignancy J Clin Med. 2021 Oct 19; 10(20). . View in PubMed
  • Clinico-pathological significance of suspicious peritoneal cytology in endometrial cancer J Surg Oncol. 2021 Sep; 124(4):687-698. . View in PubMed
  • Correction to: Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery Radiat Oncol. 2021 Aug 25; 16(1):162. . View in PubMed
  • Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery Radiat Oncol. 2021 Jun 29; 16(1):123. . View in PubMed
  • Significance of Malignant Peritoneal Cytology on Survival of Women with Uterine Sarcoma Ann Surg Oncol. 2021 Mar; 28(3):1740-1748. . View in PubMed
  • Proposing the 3-tier staging system for improving prognostication in Stage I uterine leiomyosarcoma J Surg Oncol. 2021 Mar; 123(4):1099-1108. . View in PubMed
  • Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature Cancers (Basel). 2021 Feb 17; 13(4). . View in PubMed
  • Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer Gynecol Oncol. 2021 12; 163(3):465-472. . View in PubMed
  • Secondary haematologic malignancies in women with ovarian cancer receiving poly-ADP ribose polymerase inhibitor therapy Eur J Cancer. 2021 11; 157:59-62. . View in PubMed
  • Risk of Upper-body Adverse Events in Robot-assisted Total Laparoscopic Hysterectomy for Benign Gynecologic DiseaseJ Minim Invasive Gynecol. 2021 09; 28(9):1585-1594. e1. . View in PubMed
  • Utilization and outcomes of adjuvant systemic chemotherapy alone in high risk, early stage cervical cancer in the United States Int J Gynecol Cancer. 2021 07; 31(7):991-1000. . View in PubMed
  • Recent changes in demographics and outcomes of cervical cancer in the United States Arch Gynecol Obstet. 2021 07; 304(1):1-3. . View in PubMed
  • Decreasing utilization of minimally invasive hysterectomy for cervical cancer in the United States Gynecol Oncol. 2021 07; 162(1):43-49. . View in PubMed
  • Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States Gynecol Oncol. 2021 06; 161(3):710-719. . View in PubMed
  • Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema Am J Obstet Gynecol. 2021 06; 224(6):574-584. . View in PubMed
  • Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic Gynecol Oncol. 2021 05; 161(2):414-421. . View in PubMed
  • Surgical and oncologic outcomes of hyperthermic intraperitoneal chemotherapy for uterine leiomyosarcoma: A systematic review of literature Gynecol Oncol. 2021 04; 161(1):70-77. . View in PubMed
  • Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States Gynecol Oncol. 2021 04; 161(1):39-45. . View in PubMed
  • National trends and outcomes of morbidly obese women who underwent inpatient hysterectomy for benign gynecological disease in the USA Acta Obstet Gynecol Scand. 2021 03; 100(3):459-470. . View in PubMed
  • Proposal of an endometrial cancer staging schema with stage-specific incorporation of malignant peritoneal cytology Am J Obstet Gynecol. 2021 03; 224(3):319-321. . View in PubMed
  • Utility of the 3-tier grouping system for survival discriminatory ability in stage IIA cervical cancer Eur J Surg Oncol. 2021 02; 47(2):331-337. . View in PubMed
  • Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity Gynecol Oncol. 2021 02; 160(2):586-601. . View in PubMed
  • Survival effect of intra-operative tumor spillage during minimally invasive hysterectomy for early-stage endometrial cancer: a call for research Int J Gynecol Cancer. 2021 02; 31(2):308-309. . View in PubMed
  • Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer Gynecol Oncol. 2021 01; 160(1):32-39. . View in PubMed
  • Vesicoureteral Injury during Benign Hysterectomy: Minimally Invasive Laparoscopic Surgery versus Laparotomy J Minim Invasive Gynecol. 2020 Sep – Oct; 27(6):1354-1362. . View in PubMed
  • Conservative surgery for ovarian torsion in young women: perioperative complications and national trends BJOG. 2020 Jul; 127(8):957-965. . View in PubMed
  • Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review Cancers (Basel). 2020 May 29; 12(6). . View in PubMed
  • Implementation of multidisciplinary practice change to improve outcomes for women with placenta accreta spectrum Eur J Obstet Gynecol Reprod Biol. 2020 Mar; 246:194-196. . View in PubMed
  • Corrigendum to “Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study” [GynecolOncol. 153 (2019) 368-375]. Gynecol Oncol. 2020 Mar; 156(3):749. . View in PubMed
  • Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells Gynecol Oncol. 2020 12; 159(3):869-876. . View in PubMed
  • Malignant peritoneal cytology in endometrial cancer: Areas of unmet need for evidence Eur J Cancer. 2020 11; 140:149-150. . View in PubMed
  • Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer Gynecol Oncol. 2020 10; 159(1):43-51. . View in PubMed
  • Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial Gynecol Oncol. 2020 10; 159(1):150-156. . View in PubMed
  • Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia Int J Gynecol Cancer. 2020 09; 30(9):1331-1339. . View in PubMed
  • Financial viewpoint of minimally invasive radical hysterectomy for early cervical cancer: another disadvantage? Int J Gynecol Cancer. 2020 09; 30(9):1464.. View in PubMed
  • Minimally invasive radical hysterectomy for early-stage cervical cancer: Volume-outcome relationship in the early experience period Gynecol Oncol. 2020 08; 158(2):390-396. . View in PubMed
  • Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer Eur J Cancer. 2020 07; 133:33-46. . View in PubMed
  • Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic Gynecol Oncol. 2020 07; 158(1):37-43. . View in PubMed
  • Minimally invasive surgery for early-stage ovarian cancer: Association between hospital surgical volume and short-term perioperative outcomes Gynecol Oncol. 2020 07; 158(1):59-65. . View in PubMed
  • Cesarean radical hysterectomy for cervical cancer in the United States: a national study of surgical outcomesAm J Obstet Gynecol. 2020 05; 222(5):507-511. e2. . View in PubMed
  • Significance of lymph node ratio on survival of women with borderline ovarian tumors Arch Gynecol Obstet. 2020 05; 301(5):1289-1298. . View in PubMed
  • Temporal trends of subsequent breast cancer among women with ovarian cancer: a population-based study Arch Gynecol Obstet. 2020 05; 301(5):1235-1245. . View in PubMed
  • Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored Epidemiology. 2020 05; 31(3):402-408. . View in PubMed
  • Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study Gynecol Oncol. 2020 04; 157(1):21-28. . View in PubMed
  • Evolving population-based statistics for rare epithelial ovarian cancers Gynecol Oncol. 2020 04; 157(1):3-11. . View in PubMed
  • Association between hospital surgical volume and perioperative outcomes of fertility-sparing trachelectomy for cervical cancer: A national study in the United States Gynecol Oncol. 2020 04; 157(1):173-180. . View in PubMed
  • Minimally invasive interval debulking surgery after neoadjuvant chemotherapy for metastatic ovarian cancer: a national study in the United States Arch Gynecol Obstet. 2020 03; 301(3):863-866. . View in PubMed
  • Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy Gynecol Oncol. 2020 01; 156(1):100-106. . View in PubMed
  • A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer Clin Cancer Res. 2020 03 01; 26(5):1009-1016. . View in PubMed
  • Minimally Invasive Surgery and Risk of Capsule Rupture for Women With Early-Stage Ovarian Cancer JAMA Oncol. 2020 07 01; 6(7):1110-1113. . View in PubMed
  • Treatment and outcome of placenta percreta: Primary cesarean hysterectomy versus conservative management Eur J Obstet Gynecol Reprod Biol. 2020 Jan; 244:201-203. . View in PubMed
  • Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence Curr Oncol Rep. 2020 02 12; 22(3):28. . View in PubMed
  • Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies J Surg Oncol. 2019 Nov 19. . View in PubMed
  • Expression of the luteinizing hormone receptor (LHR) in ovarian cancer BMC Cancer. 2019 Nov 15; 19(1):1114. . View in PubMed
  • Temporal trends and characteristics of suicide among women with gynecologic malignancy in the United States Gynecol Oncol Rep. 2019 Nov; 30:100510. . View in PubMed
  • Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies Gynecol Oncol Rep. 2019 Nov; 30:100497. . View in PubMed
  • Dysregulation of Placental Functions and Immune Pathways in Complete Hydatidiform Moles Int J Mol Sci. 2019 Oct 10; 20(20). . View in PubMed
  • Tumor characteristics and outcome of uterine carcinosarcoma in women aged =80 years Surg Oncol. 2019 Jun; 29:25-32. . View in PubMed
  • Decreasing Trends of Secondary Primary Colorectal Cancer among Women with Uterine Cancer: A Population-Based Analysis J Clin Med. 2019 May 20; 8(5). . View in PubMed
  • Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer Gynecol Oncol. 2019 10; 155(1):39-50. . View in PubMed
  • Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer Gynecol Oncol. 2019 09; 154(3):505-515. . View in PubMed
  • Patterns of utilization and outcome of ovarian conservation for young women with minimal-risk endometrial cancer Gynecol Oncol. 2019 07; 154(1):45-52. . View in PubMed
  • Decreasing secondary primary uterine cancer after breast cancer: A population-based analysis Gynecol Oncol. 2019 07; 154(1):169-176. . View in PubMed
  • Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective study Arch Gynecol Obstet. 2019 06; 299(6):1641-1649. . View in PubMed
  • Utero-ovarian preservation and overall survival of young women with early-stage borderline ovarian tumors Arch Gynecol Obstet. 2019 06; 299(6):1651-1658. . View in PubMed
  • Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes Gynecol Oncol. 2019 05; 153(2):230-237. . View in PubMed
  • Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study Gynecol Oncol. 2019 05; 153(2):368-375. . View in PubMed
  • Association of statins, aspirin, and venous thromboembolism in women with endometrial cancer Gynecol Oncol. 2019 03; 152(3):605-611. . View in PubMed
  • Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer Ann Oncol. 2019 06 01; 30(6):1017. . View in PubMed
  • Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix J Gynecol Oncol. 2018 Nov; 29(6):e91. . View in PubMed
  • Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma Ann Surg Oncol. 2018 Nov; 25(12):3676-3684. . View in PubMed
  • Predictive Value of FDG PET/CT to Detect Lymph Node Metastases in Cervical Cancer Clin Nucl Med. 2018 Nov; 43(11):793-801. . View in PubMed
  • Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study BMC Cancer. 2018 Oct 11; 18(1):970. . View in PubMed
  • Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element Surg Oncol. 2018 Sep; 27(3):433-440. . View in PubMed
  • Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer J Gynecol Oncol. 2018 Sep; 29(5):e69. . View in PubMed
  • Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma Ann Surg Oncol. 2018 Sep; 25(9):2756-2766. . View in PubMed
  • Nivolumab use for BRCA gene mutation carriers with recurrent epithelial ovarian cancer: A case series Gynecol Oncol Rep. 2018 Aug; 25:98-101. . View in PubMed
  • Trends and outcomes of women with synchronous endometrial and ovarian cancer Oncotarget. 2018 Jun 19; 9(47):28757-28771. . View in PubMed
  • Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery J Surg Oncol. 2018 Mar; 117(3):488-496. . View in PubMed
  • Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma J Surg Oncol. 2018 Feb; 117(2):236-244. . View in PubMed
  • Clinical utility of CA-125 in the management of uterine carcinosarcoma J Gynecol Oncol. 2018 11; 29(6):e88. . View in PubMed
  • Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer Gynecol Oncol. 2018 11; 151(2):250-256. . View in PubMed
  • Trachelectomy for stage IB1 cervical cancer with tumor size >2 cm: trends and characteristics in the United States J Gynecol Oncol. 2018 11; 29(6):e85. . View in PubMed
  • Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer Am J Clin Oncol. 2018 09; 41(9):851-860. . View in PubMed
  • Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis Gynecol Oncol. 2018 09; 150(3):501-508. . View in PubMed
  • Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer Gynecol Oncol. 2018 05; 149(2):301-309. . View in PubMed
  • Trends of uterine carcinosarcoma in the United States J Gynecol Oncol. 2018 03; 29(2):e22. . View in PubMed
  • Trends in single women with malignancy of the uterine cervix in United States J Gynecol Oncol. 2018 03; 29(2):e24. . View in PubMed
  • Fully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma Arch Gynecol Obstet. 2018 03; 297(3):749-756. . View in PubMed
  • Reply Am J Obstet Gynecol. 2018 02; 218(2):264. . View in PubMed
  • Significance of venous thromboembolism in women with uterine carcinosarcoma Gynecol Oncol. 2018 02; 148(2):267-274. . View in PubMed
  • Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane Ann Oncol. 2018 05 01; 29(5):1195-1202. . View in PubMed
  • A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses Clin Cancer Res. 2018 05 15; 24(10):2285-2293. . View in PubMed
  • Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer J Surg Oncol. 2017 Sep; 116(4):482-491. . View in PubMed
  • Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: are these two different entities? Arch Gynecol Obstet. 2017 Jun; 295(6):1459-1468.. View in PubMed
  • Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy Gynecol Oncol. 2017 Apr; 145(1):41-49. . View in PubMed
  • Significance of uterine corpus tumor invasion in early-stage cervical cancer Eur J Surg Oncol. 2017 Apr; 43(4):725-734. . View in PubMed
  • Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma Gynecol Oncol. 2017 Feb; 144(2):329-335. . View in PubMed
  • Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma Gynecol Oncol. 2017 12; 147(3):565-571. . View in PubMed
  • A pilot study in using deep learning to predict limited life expectancy in women with recurrent cervical cancer Am J Obstet Gynecol. 2017 12; 217(6):703-705. . View in PubMed
  • Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer Gynecol Oncol. 2017 12; 147(3):558-564. . View in PubMed
  • Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States Int J Gynecol Cancer. 2017 10; 27(8):1737-1746. . View in PubMed
  • Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer Obstet Gynecol. 2017 08; 130(2):403-410. . View in PubMed
  • Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma Gynecol Oncol. 2017 04; 145(1):78-87. . View in PubMed
  • Extent of pelvic lymphadenectomy and use of adjuvant vaginal brachytherapy for early-stage endometrial cancer Gynecol Oncol. 2017 03; 144(3):515-523. . View in PubMed
  • Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors Gynecol Oncol. 2017 03; 144(3):496-502. . View in PubMed
  • Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer Obstet Gynecol. 2017 01; 129(1):139-151. . View in PubMed
  • A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer Int J Cancer. 2016 Dec 15; 139(12):2646-2654. . View in PubMed
  • Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response Gynecol Oncol. 2016 Dec; 143(3):650-654. . View in PubMed
  • Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer Obstet Gynecol. 2016 Jul; 128(1):127-137. . View in PubMed
  • Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis Ann Surg Oncol. 2016 Mar; 23(3):959-67. . View in PubMed
  • Predictive Factor of Conversion to Laparotomy in Minimally Invasive Surgical Staging for Endometrial Cancer Int J Gynecol Cancer. 2016 Feb; 26(2):290-300. . View in PubMed
  • Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer Menopause. 2016 Feb; 23(2):189-96. . View in PubMed
  • Timing of Intrauterine Manipulator Insertion During Minimally Invasive Surgical Staging and Results of Pelvic Cytology in Endometrial Cancer J Minim Invasive Gynecol. 2016 Feb 01; 23(2):234-41. . View in PubMed
  • Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer Obstet Gynecol. 2016 10; 128(4):761-70. . View in PubMed
  • Significance of venous thromboembolism in women with cervical cancer Gynecol Oncol. 2016 09; 142(3):405-12. . View in PubMed
  • Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma Ann Oncol. 2016 07; 27(7):1257-66. . View in PubMed
  • Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk Obstet Gynecol. 2016 05; 127(5):828-836. . View in PubMed
  • Contributing factors for menopausal symptoms after surgical staging for endometrial cancer Menopause. 2016 05; 23(5):535-43. . View in PubMed
  • Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C Clin Immunol. 2015 Dec; 161(2):197-208. . View in PubMed
  • Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia Gynecol Oncol. 2015 Nov; 139(2):261-7. . View in PubMed
  • Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer J Surg Oncol. 2015 Nov; 112(6):669-76. . View in PubMed
  • Effects of imiquimod on vulvar Paget’s disease: a systematic review of literature Gynecol Oncol. 2015 Oct; 139(1):165-71. . View in PubMed
  • Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma Eur J Cancer. 2015 Sep; 51(14):1978-88. . View in PubMed
  • Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer Gynecol Oncol. 2015 Aug; 138(2):332-8. . View in PubMed
  • Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series Gynecol Oncol Rep. 2015 Aug; 13:36-9. . View in PubMed
  • RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon a-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma Ann Oncol. 2015 Jul; 26(7):1378-84. . View in PubMed
  • In reply Obstet Gynecol. 2015 Jun; 125(6):1498. . View in PubMed
  • Population distribution of lifetime risk of ovarian cancer in the United States Cancer Epidemiol Biomarkers Prev. 2015 Apr; 24(4):671-676. . View in PubMed
  • Escalation of oncologic services at the end of life among patients with gynecologic cancer at an urban, public hospital J Oncol Pract. 2015 Mar; 11(2):e163-9. . View in PubMed
  • Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome Obstet Gynecol. 2015 Feb; 125(2):424-433. . View in PubMed
  • Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion Gynecol Oncol. 2015 Feb; 136(2):198-204. . View in PubMed
  • [OUTCOME OF PELVIC EXENTERATION FOR LOCALLY ADVANCED CANCER OF THE PELVIC ORGANS] Vopr Onkol. 2015; 61(3):448-51. . View in PubMed
  • Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium PLoS One. 2015; 10(7):e0130909. . View in PubMed
  • Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer Ann Surg Oncol. 2014 Dec; 21(13):4246-55. . View in PubMed
  • Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors Cancer Chemother Pharmacol. 2014 Dec; 74(6):1227-34. . View in PubMed
  • Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma Gynecol Oncol. 2014 Jun; 133(3):473-9. . View in PubMed
  • Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer Obstet Gynecol. 2014 May; 123(5):957-965. . View in PubMed
  • Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer Ann Oncol. 2014 Mar; 25(3):592-598. . View in PubMed
  • A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube Gynecol Oncol. 2014 Mar; 132(3):517-25. . View in PubMed
  • Abdominal aortic resection and Y-graft placement to achieve complete cytoreduction in stage IIIc ovarian carcinoma Obstet Gynecol. 2014 Feb; 123(2 Pt 2 Suppl 2):486-488. . View in PubMed
  • [Results of surgical treatment of oral cavity cancer T1-2N0M0] Vestn Khir Im I I Grek. 2014; 173(2):52-6. . View in PubMed
  • Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer Ann Oncol. 2014 Jan; 25(1):107-16. . View in PubMed
  • [Immediate and long-term results of treatment after pelvic exenteration for locally advanced cervical cancer] Vopr Onkol. 2014; 60(3):319-22. . View in PubMed
  • Endometrial echo complex thickness in postmenopausal endometrial cancer Gynecol Oncol. 2013 Oct; 131(1):109-12. . View in PubMed
  • Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative Gynecol Oncol. 2013 Sep; 130(3):403-6. . View in PubMed
  • Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer Ann Oncol. 2013 Jul; 24(7):1792-1801. . View in PubMed
  • Predictive model of venous thromboembolism in endometrial cancer Gynecol Oncol. 2013 Mar; 128(3):544-51. . View in PubMed
  • [Microsurgical autografting for reconstruction of head and neck oncological defectsAn analysis of 60 cases]. Vestn Khir Im I I Grek. 2013; 172(1):85-90. . View in PubMed
  • Successful extraction of cardiac-extending intravenous leiomyomatosis through gonadal veinFertil Steril. 2012 Nov; 98(5):1341-5. e1. . View in PubMed
  • Significance of lymphovascular space invasion in epithelial ovarian cancer Cancer Med. 2012 Oct; 1(2):156-64. . View in PubMed
  • Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer Cancer Invest. 2012 May; 30(4):295-9. . View in PubMed
  • Significance of perioperative infection in survival of patients with ovarian cancer Int J Gynecol Cancer. 2012 Feb; 22(2):245-53. . View in PubMed
  • Long-term pegylated liposomal doxorubicin use and oromaxillary squamous cell carcinoma in endometrial cancer Oncologist. 2012; 17(12):1598-9. . View in PubMed
  • [Pelvic exenteration in surgery for colorectal cancer] Vopr Onkol. 2012; 58(3):363-8. . View in PubMed
  • [Characteristics of tumor growth in patients with locally-advanced gastric cancer] Vopr Onkol. 2011; 57(3):370-2. . View in PubMed
  • [Ways to improve the quality of life of elderly and senile patients after the operation by Brikker] Adv Gerontol. 2011; 24(4):668-73. . View in PubMed
  • Genome-scale screen for DNA methylation-based detection markers for ovarian cancer PLoS One. 2011; 6(12):e28141. . View in PubMed
  • Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type Obstet Gynecol. 2010 Nov; 116(5):1150-7. . View in PubMed
  • Overcoming platinum resistance in ovarian carcinoma Expert Opin Investig Drugs. 2010 Nov; 19(11):1339-54. . View in PubMed
  • Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study Ann Oncol. 2010 Aug; 21(8):1712-1717. . View in PubMed
  • [Outcomes of surgical treatment for locally advanced gastric cancer] Vopr Onkol. 2010; 56(1):24-8. . View in PubMed
  • Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study J Clin Oncol. 2009 Mar 01; 27(7):1069-74. . View in PubMed
  • [Palliative resection in esophageal cancer] Vopr Onkol. 2009; 55(1):56-9. . View in PubMed
  • [Quality of life of patients with breast cancer receiving hormonal therapy, depending on age and marital status] Vopr Onkol. 2009; 55(3):310-3. . View in PubMed
  • Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab Clin Cancer Res. 2008 Nov 15; 14(22):7554-63. . View in PubMed
  • Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia J Clin Oncol. 2008 Jan 01; 26(1):76-82. . View in PubMed
  • A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia Gynecol Oncol. 2007 Sep; 106(3):558-66. . View in PubMed
  • Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study Am J Clin Oncol. 2007 Aug; 30(4):428-31. . View in PubMed
  • Therapeutic vaccination for HPV induced cervical cancers Dis Markers. 2007; 23(4):337-52. . View in PubMed
  • Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status J Clin Oncol. 2006 Sep 10; 24(26):4324-32. . View in PubMed
  • Feasibility of laparoscopic extraperitoneal surgical staging for locally advanced cervical carcinoma in a gynecologic oncology fellowship training program J Minim Invasive Gynecol. 2006 Sep-Oct; 13(5):391-7. . View in PubMed
  • Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes Int J Gynecol Cancer. 2006 May-Jun; 16(3):1336-41. . View in PubMed
  • Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix Gynecol Oncol. 2006 Feb; 100(2):288-93. . View in PubMed
  • Pregnancy after radical vaginal trachelectomy: maybe not such a risky undertaking after all Gynecol Oncol. 2005 Jul; 98(1):1-2. . View in PubMed
  • Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors Gynecol Oncol. 2005 Apr; 97(1):266-70. . View in PubMed
  • Phase I clinical trial of topotecan and pegylated liposomal doxorubicin Cancer Invest. 2005; 23(8):665-70. . View in PubMed
  • The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management Eur J Gynaecol Oncol. 2005; 26(2):129-42. . View in PubMed
  • Algorithm guides ICP infection investigation Hosp Case Manag. 2004 Nov; 12(11):167-8. . View in PubMed
  • Extraperitoneal laparoscopic lymph node staging: the University of Southern California experience Gynecol Oncol. 2004 Oct; 95(1):189-92. . View in PubMed
  • Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer Gynecol Oncol. 2004 May; 93(2):493-8. . View in PubMed
  • Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy Clin Cancer Res. 2004 Apr 15; 10(8):2681-6. . View in PubMed
  • [Comparative clinical evaluation of the effectiveness of modified radical mastectomy and organ-preserving therapy in localized breast cancer (pT1-2N0M0)] Vopr Onkol. 2004; 50(1):99-100. . View in PubMed
  • Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma Gynecol Oncol. 2003 Mar; 88(3):419-23. . View in PubMed
  • Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome Cancer. 2001 Jan 01; 91(1):90-100. . View in PubMed
  • The use of a pelvic displacement prosthesis to exclude the small intestine from the radiation field following radical hysterectomy Gynecol Oncol. 2000 Dec; 79(3):438-43. . View in PubMed
  • A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive Clin Cancer Res. 2000 Sep; 6(9):3406-16. . View in PubMed
  • Phase II study of liposomal doxorubicin in advanced gynecologic cancers Gynecol Oncol. 2000 Aug; 78(2):143-7. . View in PubMed
  • Effects of extended lamivudine therapy in Asian patients with chronic hepatitis BAsia Hepatitis Lamivudine Study Group. Gastroenterology. 2000 Jul; 119(1):172-80. . View in PubMed
  • A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix Gynecol Oncol. 2000 Jan; 76(1):63-6. . View in PubMed
  • [Ulcerated forms of gastric cancer as a clinical problem] Vestn Khir Im I I Grek. 2000; 159(5):110-3. . View in PubMed
  • [Long-term outcome of surgical treatment of patients with esophageal cancer] Vestn Khir Im I I Grek. 2000; 159(4):33-6. . View in PubMed
  • Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study Am J Obstet Gynecol. 1999 Feb; 180(2 Pt 1):276-82. . View in PubMed
  • [Lymph node dissection in esophageal cancer] Vestn Khir Im I I Grek. 1999; 158(5):50-3. . View in PubMed
  • A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study Gynecol Oncol. 1998 Sep; 70(3):334-8. . View in PubMed
  • Clinical utility? J Reprod Med. 1998 May; 43(5):403-7.. View in PubMed
  • Small cystic pelvic masses in older women: is surgical removal necessary? Gynecol Oncol. 1998 Apr; 69(1):1-2.. View in PubMed
  • Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix Gynecol Oncol. 1998 Mar; 68(3):220-5. . View in PubMed
  • Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination J Natl Cancer Inst. 1998 Feb 04; 90(3):238-42. . View in PubMed
  • Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen Obstet Gynecol. 1997 Nov; 90(5):759-64. . View in PubMed
  • Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin) Gynecol Oncol. 1997 Aug; 66(2):290-4. . View in PubMed
  • Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study Gynecol Oncol. 1997 May; 65(2):336-42. . View in PubMed
  • Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer Obstet Gynecol. 1997 Apr; 89(4):493-500. . View in PubMed
  • Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation J Clin Oncol. 1997 Mar; 15(3):987-93. . View in PubMed
  • [Successful surgical treatment of cancer with multiple location] Vopr Onkol. 1997; 43(2):230. . View in PubMed
  • Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical carcinoma Am J Clin Oncol. 1996 Oct; 19(5):433-8. . View in PubMed
  • [Variants in the definitive organization of the lumbar lymph-conducting pathways in the applied aspect] Vestn Khir Im I I Grek. 1996; 155(6):49-53. . View in PubMed
  • Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study J Clin Oncol. 1995 Nov; 13(11):2752-6. . View in PubMed
  • The role of endocervical curettage at cervical conization for high-grade dysplasia Obstet Gynecol. 1995 Feb; 85(2):197-201. . View in PubMed
  • Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography AJR Am J Roentgenol. 1995 Feb; 164(2):381-6. . View in PubMed
  • Intraperitoneal 5-fluoro-2′-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study Cancer Chemother Pharmacol. 1995; 37(1-2):32-8. . View in PubMed
  • The significance of positive margins in loop electrosurgical cone biopsies Obstet Gynecol. 1994 Dec; 84(6):996-1000. . View in PubMed
  • Paclitaxel (Taxol) in heavily pretreated ovarian cancer: antitumor activity and complications Ann Oncol. 1994 Nov; 5(9):827-33. . View in PubMed
  • Death from anaphylaxis to cisplatin: a case report Gynecol Oncol. 1994 Apr; 53(1):121-2. . View in PubMed
  • Cervical cancer in pregnancy: reporting on planned delay in therapy Obstet Gynecol. 1993 Oct; 82(4 Pt 1):598-602. . View in PubMed
  • Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive cancer of the cervix Gynecol Oncol. 1993 Aug; 50(2):179-84. . View in PubMed
  • Dedifferentiated extrauterine adenosarcoma responsive to chemotherapy Gynecol Oncol. 1993 Jun; 49(3):389-94. . View in PubMed
  • Reasons for inappropriate simple hysterectomy in the presence of invasive cancer of the cervix Obstet Gynecol. 1992 Apr; 79(4):485-9. . View in PubMed
  • High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancer Cancer. 1991 Nov 01; 68(9):1890-4. . View in PubMed
  • Unsuspected invasive squamous cell carcinoma of the vulva in young women Gynecol Oncol. 1991 May; 41(2):182-5. . View in PubMed
  • Primary adenocarcinoma of the breast arising in the vulva Obstet Gynecol. 1990 Sep; 76(3 Pt 2):537-9. . View in PubMed

Similar People